erythromycin cyclocarbonate

Poland

Drugs containing this active substance

  • DAVERCIN

    The medicinal product is used for the topical treatment of acne vulgaris.

    Form: solution, topical

    Active substance Dosage
    erythromycin cyclocarbonate 25 mg

    ATC: D10AF02

    Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.

  • DAVERCIN

    The medicinal product is used in infections of the upper respiratory tract (e.g., pharyngitis, sinusitis), lower respiratory tract (e.g., pneumonia, bronchitis), skin and soft tissues (e.g., abscesses, boils), the gastrointestinal tract, as well as in dentistry (e.g., gingivitis) and in the case of scarlet fever.

    Form: tablets, film-coated

    Active substance Dosage
    erythromycin cyclocarbonate 250 mg

    ATC: J01FA01

    Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.

  • DAVERCIN

    Davercin is used to treat various bacterial infections, such as respiratory tract infections (e.g., pneumonia), pertussis in children, urethritis, gastrointestinal infections, pityriasis rosea, chancroid, and certain skin and soft tissue infections.

    Form: powder for preparation of oral suspension

    Active substance Dosage
    erythromycin cyclocarbonate 150 mg

    ATC: J01FA01

    Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.

  • DAVERCIN

    The medicinal product is used for the topical treatment of acne vulgaris.

    Form: gel

    Active substance Dosage
    erythromycin cyclocarbonate 25 mg/g

    ATC: D10AF02

    Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.

  • DAVERCIN

    It is used for the topical treatment of acne vulgaris.

    Form: gel

    Active substance Dosage
    erythromycin cyclocarbonate 25 mg/g

    ATC: D10AF02

    Manufacturer: Tarchomin Pharmaceutical Works 'Polfa' S.A.